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Objective: To elucidate all of the characteristics of childhood epilepsy, we performed a long-term follow-up study on the patients
who visited Okayama University Hospital.
Subjects and methods: We retrospectively investigated the patients who were involved in the previous epidemiological study and
visited Okayama University Hospital for a period of 10 years after December 31, 1999.
Results: Overall, there were 350 patients’ medical records that were evaluated, and 258 patients with complete clinical informa-
tion available for a 10-year period were enrolled. Ten patients died and the remaining 82 were lost to follow-up. Of 258 patients with
complete information, 153 (59.3%) were seizure-free for at least 5 years. One hundred thirty (50.4%) had intellectual disabilities and
77 (29.8%) had motor disabilities, including 75 (29.1%) with both disabilities on December 31, 2009. Thirty-four patients of 350
(9.7%) changed the epilepsy classiﬁcation during follow-up. With regard to ten patients who died, nine of them had symptomatic
epilepsy, particularly those with severe underlying disorders with an onset during the ﬁrst year of life.
Conclusion: Clinical status considerably changed during the decade-long follow-up period in childhood epilepsy. Changes in the
epilepsy diagnosis are especially important and should be taken into account in the long-term care of children with epilepsy.
 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
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To determine all of the characteristics of childhood
epilepsy, it is important to investigate its epidemiology
not only on a single prevalence day but also the detailed
clinical course of the aﬀected patients over a long period
after the prevalence day, because epilepsy is chronic and
includes heterogeneous disorders with variable out-http://dx.doi.org/10.1016/j.braindev.2016.10.011
0387-7604/ 2016 The Japanese Society of Child Neurology. Published by E
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700-8558, Japan. Fax: +81 86 235 7377.
E-mail address: yoshiyukih84@hotmail.com (Y. Hanaoka).comes. Epidemiological studies of childhood epilepsy
have been undertaken in various countries [1–7]. How-
ever, there have been few such studies with long-term
follow-up for childhood epilepsy in Japan [8]. Most of
the published long-term follow-up epidemiological stud-
ies assessed outcomes in terms of remission or death [8–
13], and there are only a few studies on the course of epi-
lepsy including changes in classiﬁcation [14,15].
It is possible that diagnosis of epilepsy classiﬁcation
may be changed because of age-dependent changes
and/or identiﬁcation of previously unknown etiology
through advances in neuroimaging and genetic examina-
tion. Thus, we aimed to clarify the long-term course oflsevier B.V. All rights reserved.
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perspective. Oka et al. performed a large-scale
population-based survey of childhood epilepsy in
Okayama Prefecture, Japan using the prevalence day
of December 31, 1999 [7]. Based on this study, we fol-
lowed patients who had visited Okayama University
Hospital for a period of 10 years. We aimed to disclose
the decade-long burdens of childhood epilepsy on the
patients, their family and society in this study.
2. Subjects and methods
2.1. Patients
Our previous neuroepidemiological survey of child-
hood epilepsy was based on all children aged <13 years
living in Okayama Prefecture, Japan [7]. The prevalence
day was December 31, 1999. The prevalence rate and
distribution of epilepsy and epileptic syndromes were
reported according to the classiﬁcation by the Interna-
tional League Against Epilepsy (ILAE) in 1989 [16]. In
this previous study, we determined that the patients
who had taken antiepileptic drugs (AEDs) and/or who
had experienced at least one seizure during the last ﬁve
years had active epilepsy. Of the 2220 identiﬁed patients
with active epilepsy, 510 (289 males, 221 females) had
visited the Department of Child Neurology at Okayama
University Hospital at least once, and clinical informa-
tion was available after the prevalence day for 350
patients. Out of the 350 patients, 82 were lost to
follow-up during the 10-year period after December
31,1999. In the present study, we performed a follow-
up investigation of the remaining 268 patients (com-
posed of Group 1, which contained 258 live patients,
and Group 2, which contained 10 who died during fol-
low–up) to clarify their detailed, clinical course of epi-
lepsy, seizure outcomes, and disability. We used the
same deﬁnition of active epilepsy as the previous study
for consistency. Similarly, we also used the same ILAE
1989 classiﬁcation [16], but new diagnostic entities such
as Panayiotopoulos syndrome (PS) were included
according to Berg et al. [17]. This study was approved
by the Okayama University Ethics Committee with the
following stipulation: investigation of patients who vis-
ited the Okayama University Hospital was approved
but that of patients who did not visit this hospital was
not permitted as a condition of ethics approval for the
initial study.
2.2. Statistical analysis
We performed the Wilcoxon signed-rank test to com-
pare the frequency of seizures and the number of AEDs
between 1999 and 2009. The frequency of seizures (no
seizure P5 years, no seizure for >1 year and <5 years,
yearly, monthly, weekly, daily) was ranked as indices 1through 6, and the number of AEDs (zero, one, two,
three, four or more) as indices 1 through 4 (Table 4).
We used SPSS Statistics (Japanese ver. 23; IBM Japan,
Ltd., Tokyo, Japan) for this analysis.
3. Results
3.1. Group 1 patients
Distribution of the epilepsy classiﬁcation in the 258
patients in 1999 and 2009 is shown in Table 1 and Sup-
plementary Fig. 1: 163 and 163, respectively, were diag-
nosed with localization-related epilepsy, 72 and 68,
respectively, with generalized epilepsy, and 14 and 19,
respectively, with epilepsies undetermined (either focal
or generalized). Suﬃcient information to make an epi-
lepsy classiﬁcation was not available for nine and eight
patients, respectively.
With respect to the age distribution pattern, ﬁve
(1.9%) patients were under one year of age, 55 (21.3%)
were 1–4 years old, 124 (48.1%) were 5–9 years old,
and 74 (28.7%) were 10–12 years old in 1999.
The mean age of the 258 patients was 7 years
7 months (range, 3 months–12 years 11 months) on
December 31, 1999. The mean age at onset of epilepsy
was exactly 3 years (range, 0 months–11 years
10 months), and 87 patients (33.7%) had an initial sei-
zure during the ﬁrst year of life.
Patients’ underlying diseases are listed in Table 2 and
include perinatal complications, cerebral dysgenesis/
tumor, neurocutaneous syndromes, cerebrovascular dis-
order, genetic neurologic disease, sequelae of the central
nervous system infection and hypoxic-ischemic
encephalopathy. Etiologies were newly identiﬁed during
follow-up in nine patients including focal cortical dys-
plasia (FCD) in three, SCN1A mutations in three, hip-
pocampal sclerosis in two, and dysembryoplastic
neuroepithelial tumor (DNT) in one. In addition, hip-
pocampal sclerosis developed after encephalitis during
follow-up in one patient. On December 31, 2009, no
underlying diseases were found in the remaining 159
(61.6%) patients including 54 (20.9%) with only a family
history of genetic factors for epilepsy or febrile seizures.
Diagnosis of epilepsy classiﬁcation was changed dur-
ing follow-up in 26 patients as shown in Table 3. One
patient diagnosed with idiopathic localization-related
epilepsy (ILRE; childhood epilepsy with occipital parox-
ysms) on the prevalence day was re-diagnosed with PS
by 2009. Of 82 patients diagnosed with symptomatic
localization-related epilepsy (SLRE) on the prevalence
day, two showed evolution to diﬀerent types of epilepsy
(one to Lennox-Gastaut syndrome [LGS] and the other
to epilepsy with continuous spike-waves during slow-
wave sleep [ECSWS]). Another patient who, from
infancy, had seizures that were often associated with
fever but was still in the early phase of the disease on
Table 1
Epilepsy classiﬁcation.
Group 1 (n = 258) Group 2 (n = 10)
December 31, 1999 December 31, 2009 December 31, 1999 Death
Localization-related epilepsy 163 (63.2%) 163 (63.2%) 5 (50.0%) 4 (40.0%)
Idiopathic 9 10 0 0
Benign childhood epilepsy with centrotemporal spike 8 9 0 0
Childhood epilepsy with occipital paroxysms 1 0 0 0
Panayiotopoulos syndrome 0 1 0 0
Symptomatic 82 89 4 4
Cryptogenic 72 64 1 0
Generalized epilepsy 72 (27.9%) 68 (26.4%) 5 (50.0%) 5 (50.0%)
Idiopathic 15 16 1 1
Childhood absence epilepsy 7 8 0 0
Juvenile absence epilepsy 0 0 1 1
Juvenile myoclonic epilepsy 0 0 0 0
Epilepsy with grand mal seizures on awakening 1 0 0 0
Unclassiﬁed in detail 7 8 0 0
Cryptogenic or symptomatic 42 34 1 1
West syndrome 20 10 1 0
Lennox-Gastaut syndrome 4 7 0 1
Epilepsy with myoclonic-astatic seizures 0 0 0 0
Unclassiﬁed in detail 18 17 0 0
Symptomatic 15 18 3 3
Early myoclonic encephalopathy 1 1 1 1
Others 4 5 0 0
Unclassiﬁed in detail 10a 12 2 2
Epilepsies undetermined whether focal or generalized 14 (5.4%) 19 (7.4%) 0 (0%) 1 (10.0%)
Dravet syndrome 7 10 0 1
Epilepsy with continuous spike-waves during slow-wave sleep 3 4 0 0
Landau-Kleﬀner syndrome 3 3 0 0
Unclassiﬁed in detail 1 2 0 0
Unclassiﬁed because of lack of information 9 (3.5%) 8 (3.1%) 0 (0%) 0 (0%)
Total 258 258 10 10
Epilepsy classiﬁcation was performed on the clinical information on December 31, 1999. Italic values indicate summed numbers of patients in the
subgroups.
a One of the patients who had symptomatic generalized epilepsy (SGE) on December 31, 1999, had Ohtahara syndrome and subsequent West
syndrome before SGE.
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drome (DS) because of recurrent seizures that were typ-
ical of DS and because the SCN1A mutation was
detected during follow-up. Another patient was re-
diagnosed with epilepsy but it was undetermined
whether it was focal or generalized because she had only
partial seizures by the prevalence day and she had gen-
eralized seizures including atypical absences and tonic
seizures afterward. Another patient was initially diag-
nosed with SLRE because of early slow language devel-
opment, but he was re-diagnosed with benign childhood
epilepsy with centrotemporal spike (BECTS) and he
developed normally during the follow-up period.
Of the 72 patients with a diagnosis of cryptogenic
localization-related epilepsy (CLRE) on the prevalence
day, ﬁve were re-diagnosed with SLRE including two
in whom hippocampal sclerosis (mesial temporal lobe
epilepsy) was detected and three in whom FCD was
detected by follow-up MRI each in the temporal, pari-
etal and occipital lobes. Another two patients werere-diagnosed with DS: one re-diagnosis was similar to
the above patient with an initial diagnosis of SLRE,
and the other had atypical DS, which was diagnosed
by the detection of an SCN1A mutation. Another
patient with an initial diagnosis of CLRE who had
two generalized convulsive seizures with rolandic spikes
on interictal EEG before the prevalence day was re-
diagnosed with childhood absence epilepsy (CAE)
because of the occurrence of absence seizures with typi-
cal 3-Hz diﬀuse spike-wave bursts on subsequent EEG.
Of the 20 patients with an initial diagnosis of WS, 10
patients remained with this diagnosis because of seizure-
freedom during the follow-up period, and epilepsy
evolved to SLRE in seven patients, to LGS in one
patient and to other types of symptomatic generalized
epilepsy (SGE) in two patients. One patient with crypto-
genic or symptomatic generalized epilepsy and another
lacking detailed information on the prevalence day were
re-diagnosed with SGE and LGS, respectively, during
the follow-up. One patient initially had Ohtahara
Table 2
Underlying diseases and speciﬁc diagnoses.
Etiology Group 1 (n = 258) Group 2 (n = 10)
December 31, 1999 December 31, 2009 December 31, 1999 December 31, 2009
Perinatal complications 28 28 1 1
Neonatal asphyxia 18 18 1 1
Premature birth 6 6 0 0
Neonatal hypoglycemia 2 2 0 0
Periventricular leukomalacia 2 2 0 0
Cerebral dysgenesis/tumor 16 20 0 0
Cortical dysplasia 1 4 0 0
Hemimegalencephaly 3 3 0 0
FCMD 3 3 0 0
Congenital CMV 2 2 0 0
Polymicrogyria 2 2 0 0
Porencephaly 1 1 0 0
Lissencephaly 1 1 0 0
Aicardi 1 1 0 0
Agenesis of the corpus callosum 1 1 0 0
Atrophy of hemisphere 1 1 0 0
DNT 0 1 0 0
Neurocutaneous syndrome 10 10 2 2
Tuberous sclerosis 7 7 1 1
Sturge-Weber syndrome 1 1 0 0
Ito-hypomelanosis 1 1 0 0
Nevoid-basal cell carcinoma syndrome 1 1 0 0
Congenital ichthyosis 0 0 1 1
Cerebrovascular disorder 9 9 0 0
Sequel of intracranial hemorrhage 3 3 0 0
Sequel of subdural hematoma 2 2 0 0
Sequel of infarction 2 2 0 0
Cavernous hemangioma 1 1 0 0
Moyamoya-disease 1 1 0 0
Genetic neurologic disease 8 8 1 1
Angelman syndrome 4 4 0 0
Down syndrome 1 1 1 1
4p-syndrome 1 1 0 0
14p+ 1 1 0 0
Fragile X syndrome 1 1 0 0
Infection 6 5 1 1
Encephalopathy/encephalitis 4 3 1 1
Meningitis 2 2 0 0
Hypoxic-ischemic encephalopathy 5 5 0 0
Post heart operation 3 3 0 0
Near-drowning 2 2 0 0
Progressive degenerative disease 1 1 2 2
Leukodystrophy 1 1 0 0
Hunter syndrome 0 0 1 1
Niemann-Pick disease 0 0 1 1
Particular type of epilepsy 7 13 0 1
Dravet syndrome 7 10 0 1
Mesial temporal lobe epilepsy 0 3 0 0
Unknown except for genetic factors 56 54 1 1
Unknown 112 105 2 1
Italic values indicate summed numbers of patients in the subgroups. FCMD, Fukuyama type congenital muscular dystrophy.
CMV, cytomegalus virus.
DNT, dysembryoplastic neuroepithelial tumor.
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to WS, and then to SGE by December 31, 1999.For seizure frequency, 30 patients had been com-
pletely seizure free for at least 5 years before December
Table 3
Changes in epilepsy classiﬁcations during follow-up.
Group 1 (n = 258)
December 31, 1999 December 31, 2009
Idiopathic localization-related epilepsy 1 Panayiotopoulos syndrome 1
Symptomatic localization-related epilepsy 5 Lennox-Gastaut syndrome 1
Epilepsy with continuous spike-waves during slow-wave sleep 1
Dravet syndrome 1
Epilepsies undetermined whether focal or generalized 1
Benign childhood epilepsy with centrotemporal spike 1
Cryptogenic localization-related epilepsy 8 Symptomatic localization-related epilepsy 5
Dravet syndrome 2
Childhood absence epilepsy 1
West syndrome 10 Symptomatic localization-related epilepsy 7
Lennox-Gastaut syndrome 1
Symptomatic generalized epilepsy others 1
Symptomatic generalized epilepsy unclassiﬁed 1
Cryptogenic or symptomatic generalized epilepsy unclassiﬁed 1 Symptomatic generalized epilepsy unclassiﬁed 1
Lack of information 1 Lennox-Gastaut syndrome 1
Group 2 (n = 10)
December 31, 1999 Last follow up
Cryptogenic localization-related epilepsy 1 Dravet syndrome 1
West syndrome 1 Lennox-Gastaut syndrome 1
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with seizure-freedom for more than 5 years had
increased to 153. In contrast, the number of patients
with daily and weekly seizures slightly decreased from
38 and 13, respectively, to 28 and 10, respectively. These
changes during the 10-year follow-up period were statis-
tically signiﬁcant (p < 0.001) (Table 4).
Regarding disability in 1999, 139 patients had no dis-
ability, 47 had only intellectual disability, one had only
motor disability, and the remaining 71 had both intellec-
tual and motor disabilities. On December 31, 2009, the
number of patients with no disability decreased to 126,
and the number of patients with both intellectual and
motor disability increased to 75. There were 55 and
two patients with only an intellectual disability and only
a motor disability, respectively (Table 4).
Treatment of patients was assessed, and there were 37
patients who were not taking AED medications on
December 31, 1999, and this increased to 120 on Decem-
ber 31, 2009. However, the number of patients taking
two or more AEDs increased from 90 to 103 during
the 10-year follow-up period. These changes were statis-
tically signiﬁcant (p = 0.047). Two patients had surgical
treatment during the follow-up period. These patients
both underwent surgery to remove FCD and hemi-
spherotomy for a hemimegalencephaly. No patients
underwent ketogenic diet treatment during the follow-
up.
3.2. Group 2 dead patients
Ten patients (six males and four females) died during
the follow-up period, as indicated in Table 5. Theirmean age at the onset of epilepsy was exactly 2 years
(median, 6 months; range, 1 day–10 years and
7 months), and seven of these patients developed epi-
lepsy before 12 months of age. Age at death ranged from
4 to 19 years, with a mean of 13 years and 3 months.
For epilepsy diagnoses, four patients had SLRE, two
had SGE and the remaining patients had DS, early myo-
clonic encephalopathy (EME), LGS or juvenile absence
epilepsy (JAE). Eight patients had severe underlying dis-
ease, and seven of them had both intellectual and motor
disabilities and the other had only an intellectual
disability.
At the time of death, seizures were not controlled in
six patients (seizure frequency was yearly in one, weekly
in two and daily in three patients), while three patients
were completely seizure-free for more than one year.
The cause of death was drowning, which was possibly
related to seizures in one patient (patient 9, Table 5).
The cause of death seemed to be unrelated to seizures
in ﬁve patients (inﬂuenza encephalopathy, tracheal
bleeding, pneumonia and heart failure, bleeding from
renal angiomyolipoma, and aspiration pneumonia),
and it was unknown for the remaining four patients.
Patient 9 with JAE had no underlying disease or disabil-
ity. She had been diagnosed with JAE and had absence
seizures at least once per week at the time of her death,
but she died suddenly immediately after a generalized
seizure at 19 years of age.
3.3. Group of patients lost to follow-up
Of the remaining 82 patients who were lost to follow-
up during the 10-year period, we obtained information
Table 4
Seizure frequency, additional disability and antiepileptic medication.
Group 1 (n = 258) Group 2 (n = 10)
1999 2009 1999 Last
Frequency of seizurea No seizureP 5 years [1] 30 153 1 3
No seizure for >1 year and
<5 years [2]
90 32 3 0
Yearly [3] 69 17 3 1
Monthly [4] 18 18 1 0
Weekly [5] 13 10 0 2
Daily [6] 38 28 2 4
Disability None 139 126 1 1
Intellectual & motor 71 75 8 8
Intellectual only 47 55 1 1
Motor only 1 2 0 0
The number of AEDsb 0 [1] 37 120 0 0
1 [2] 128 35 4 3
2 [3] 46 44 3 1
3 [4] 35 28 3 5
P4 [5] 9 31 0 1
Unidentiﬁed 3 0 0 0
AEDs, antiepileptic drugs; [], rank index for statistical analysis.
Changes of rank indices in Group 1 during the 10-year follow-up period were statistically signiﬁcant with p < 0.001a and p = 0.047b using the
Wilcoxon signed-rank test.
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these patients: in two with an initial diagnosis of West
syndromes, epilepsy in each evolved to SLRE and
LGS, and four with initial CLRE were re-diagnosed
with PS based on the latest epilepsy classiﬁcation.
4. Discussion
Our objective was to clarify the long-term clinical
course of childhood epilepsy during a period of 10 years,
using data that followed an epidemiological study in the
restricted area of Okayama Prefecture, Japan [7]. The
investigation into changes in the epilepsy diagnosis
and classiﬁcation in the present study, from an epidemi-
ological point of view, is important because other stud-
ies on changes in the epilepsy classiﬁcation were largely
limited to certain epilepsy syndromes such as West syn-
drome and IGE [18–21]. There are still few comprehen-
sive long-term epidemiological studies on such changes
[14,15]. In addition, we could follow marginal patients
who had experienced only acute symptomatic seizures
or single unprovoked seizures with epileptiform abnor-
malities on the EEG at the time of initial prevalence
day: we could assess this group of patients because
almost all subjects had undergone EEG recordings.
In the 258 patients in the present study, onset age of
epilepsy tended to be young, with an average of
3.0 years because of the presence of more children with
infantile onset epilepsies (87 patients; 33.7%) such as
West syndrome (20 patients; 7.8%) and DS (10 patients;
3.9%) than other studies, where the proportion of
patients with these syndromes was <3% [1,4–6,22]. Ageat onset of epilepsy was highest within the ﬁrst year of
life (87 patients; 33.7%). There was a relatively high rate
of patients with intractable epilepsy and the number of
the patients with at least yearly seizures in 1999 was
138 of 258 (53.5%) in the present study, compared to
681 of 2,220 (30.7%) in the previous study [7].
4.1. Etiology
In the 258 patients in the present study, etiologies
were identiﬁed in 99 patients (38.4%) at their ﬁnal
follow-up. This percentage was similar to those in other
reports [1–4,8]. The identiﬁcation of etiologies was per-
formed during the follow-up period in nine patients,
and three patients had SCN1A mutations, three had
FCD, two had hippocampal sclerosis, and one had
DNT. Of the 159 patients with epilepsy of unknown
cause, 18 met the criteria for speciﬁc epileptic syndromes
including BECTS, PS and CAE. There were 54 patients
(20.9%) who had a family history of seizure disorders.
4.2. Seizure outcome and treatment
The number of patients with no seizures for at least
5 years markedly increased from 30 in 1999 to 153 in
2009, but the rate of seizure-free patients (153/258 or
59.3%) was somewhat low compared to the rates from
other studies, which averaged around 65% (range, 51–
76%) [8,10,12–14,21,23,24]. This may be because there
was a high percentage of patients with refractory epi-
lepsy who continued to be treated at Okayama Univer-
sity Hospital, a tertiary epilepsy center. The number of
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decreased from 69 in 1999 to 56 in 2009, suggesting that
patients with frequent seizures remained resistant to
treatment even for a decade.
For treatment, though the number of AEDs generally
decreased, antiepileptic medication was continuing in
138 patients (53.5%) at the ﬁnal follow-up. This rate
was higher than previously-reported rates of around
35% [11,23]. This may be because of the high proportion
of intractable patients.
4.3. Neurological disabilities
In the 258 patients, a total of 130 (50.4%) and 77
(29.8%) patients had an intellectual disability and a
motor disability, respectively, on December 31, 2009,
including 75 (29.1%) with both disabilities. In previous
reports, the rate of patients with the comorbidity of epi-
lepsy ranged from 24% to 39% for intellectual disability
[2,3,5,6,8,22] and from 16% to 46% for motor disability
[2,3,5,6,22]. The results of the present study were similar
to those in previous studies [2,6,22].
4.4. Changes in epilepsy diagnosis
Epilepsy classiﬁcation was changed in 26 (10.1%) of
258 patients during the decade-long follow-up. In addi-
tion, the epilepsy classiﬁcation was changed during the
follow-up for two dead patients and six of the 82
patients lost to follow-up. The reasons for these changes
include: (1) the recognition of new epileptic syndrome
such as PS; (2) age-dependent evolution of epileptic syn-
dromes; (3) detection of underlying pathology particu-
larly malformation of cortical development by
advances of neuroimaging techniques; and (4) identiﬁca-
tion of genetic abnormalities associated with epilepsy. In
previous studies, epilepsy classiﬁcation was changed in
7–33% of patients during follow-up [14,15,18–21].
Therefore, changes in the epilepsy classiﬁcation are com-
mon, and could be determined by careful observation
over a long period in the present study.
Summarizing the changes in epilepsy classiﬁcation in
all patients in the present study, ﬁve patients were re-
diagnosed with PS, a newly recognized syndrome, dur-
ing follow-up. Evolution of epileptic syndromes
occurred in 15 patients. Thirteen patients had symptoms
that evolved, as follows: from West syndrome to SLRE
in eight; LGS in three and SGE in the remaining two.
Another patient showed an evolution from SLRE to
ECSWS. The remaining patient initially had West syn-
drome and her epilepsy evolved to SLRE before 1999,
and then to LGS before 2009. West syndrome often
evolves to other disorders such as related-localization
epilepsy, LGS and other types of generalized epilepsy.
Ohtahara et al. reported that 51 of 94 patients with West
syndrome evolved to LGS [18]. Camﬁeld et al. reported
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drome, the diagnosis changed to partial epilepsy in four,
to LGS in 11, and to unspeciﬁed SGE in nine, and that it
did not change in the remaining eight [20]. In the present
study, ﬁve patients who had been initially diagnosed
with CLRE were re-diagnosed with SLRE during
follow-up because of pathology detected by MRI.
Genetic examination is helpful to identify the cause of
epilepsy, which was unavailable for a long time, partic-
ularly in DS that has a mutation in the SCN1A gene. In
the present study, the diagnosis of DS was established in
four patients by detection of SCN1A mutations during
the follow-up period. Two of these patients were less
than 18 months of age and had not yet shown all the
characteristics of DS on the prevalence day in 1999.
The other two patients had atypical DS because of an
inconspicuous intellectual disturbance on the initial
prevalence day.
We expect that more patients may be re-diagnosed as
there are further technical advances in neuroimaging
and genetic examination. For a precise epidemiological
study of epilepsy classiﬁcation, a long-term follow-up
study is required.
4.5. Mortality
Of 10 patients who died in Group 2, nine had symp-
tomatic epilepsy, particularly severe underlying disor-
ders and seven developed epilepsy during the ﬁrst year
of life. It was, therefore, suggested that the presence of
underlying disorders, neuro-deﬁcits including intellec-
tual disability, and early onset of epilepsy are among
the risk factors for death, which is consistent with previ-
ous reports [8–10,20,23–27]. Sillanpa¨a¨ et al. reported
that the mortality in epilepsy patients is three times as
high as the mortality in the general population and that
symptomatic causes and severe cognitive impairment are
among the risk factors for death [24]. They also indi-
cated that deaths in childhood occurred primarily in
the symptomatic group and were most often not related
to epilepsy but to the underlying diseases. Moseley et al.
suggested that children with epilepsy onset in the ﬁrst
year of life were over six times more likely to die than
children with later onset epilepsy [27]. We conﬁrmed
their observations in the present study.
Conversely, a 19-year-old patient (patient 9 in
Table 5) with JAE suddenly died immediately after a
generalized seizure. Although the previous reports indi-
cated that incidence of sudden unexpected death in epi-
lepsy (SUDEP) and mortality of the patients with
uncomplicated epilepsy is not higher than the general
population [9,25,26,28,29], Sillanpa¨a¨ et al. reported a
similar patient with JAE who suddenly died, probably
as a result of a brief unwitnessed seizure, and indicated
that almost all the mortality in the idiopathic/crypto-
genic group occurred in adult life [30].4.6. Limitations of the study
There were a few limitations in the present study. The
ﬁrst limitation was a high proportion of patients whose
information was unavailable: patients who did not visit
Okayama University Hospital could not be located. The
second limitation is a subject bias. Because Okayama
University Hospital is a tertiary epilepsy center for
patients with intractable epilepsy, the proportion of
patient with refractory epilepsy was higher than that
of previous studies.4.7. Conclusions
We comprehensively investigated the changes in epi-
lepsy diagnosis over a decade. This 10–year-long
follow-up was longer than most of the previous reports
and disclosed detailed clinical characteristics of child-
hood epilepsy. Etiologies of currently-unknown causes
may be identiﬁed in more patients via further advance-
ments in neuroimaging and genetic examination. To
clarify all the chronic aspects of epilepsy including sei-
zure outcome, social issues and mortality, life-long
follow-up involving a larger sample of patients may be
needed.
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